Tariffs alone will not produce sustainable generic medicine in US: IPA

The Indian Pharmaceutical Alliance believes tariffs alone will not build US generic drug manufacturing. Broader reforms are needed for fair pricing and supply chain stability. India supplies nearly fifty percent of generic medicines to the United States. Tariffs alone will not produce sustainable generic medicine onshoring. Reforms should address upstream buying groups and delayed generic competition.